Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Ellen McLaughlin

LambdaVision secures funding re artificial retina

LambdaVision has been selected by NASA for a Small Business Innovation Research (SBIR) Phase II award, worth $750,000 over two years. With the continued support...

| By Ellen McLaughlin

InveniAI in strategic partnership with TB Alliance

InveniAI® LLC has formed a strategic partnership with TB Alliance, a non-profit organization dedicated to the discovery, development, and delivery of better, faster-acting and affordable...

| By Ellen McLaughlin

BioCT welcomes Architectural Building Systems

Architectural Building Systems is a multi-generational General Contracting and Construction Management firm that was founded in 1985 to serve the ever-changing needs of customers in...

| By Ellen McLaughlin

101 College St project clears committee hurdle

Plans for a new 10-story, 500,000-square-foot bioscience building in downtown New Haven to feature lab, research, and incubator space have garnered a key approval. The...

| By Ellen McLaughlin

Sema4 and Tangen tackle COVID-19 testing

Tangen Biosciences and LabWare have agreed to enter into an  exclusive partnership whereby LabWare will distribute Tangen’s GeneSpark™ device as part of the LabWare’s Portable Disease...

| By Ellen McLaughlin

HBJ special: Leadership in a Time of Crisis

The Hartford Business Journal has produced a special online publication, Leadership in a Time of Crisis: Letters of inspiration and hope from the stae’s business...

| By Ellen McLaughlin

BioCT welcomes New England Cell Therapeutics

New England Cell Therapeutics was founded in 2019 with a mission to deliver cell therapy to patients suffering from a broad range of injuries and illnesses....

| By Ellen McLaughlin

Sema4 names Goldman Sachs executive to Board

Sema4 has appointed prominent Wall Street and technology executive R. Martin Chavez to its Board of Directors. Mr. Chavez most recently served in several senior roles...

| By Ellen McLaughlin

Cybrexa pipeline to be cited at AACR meeting

Cybrexa Therapeutics reports that two posters featuring Cybrexa’s pipeline will be presented at the American Association for Cancer Research Virtual Annual Meeting II, which will...